We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$80M
Cap. Flow
-$1.07M
Cap. Flow %
-0.52%
Top 10 Hldgs %
40.32%
Holding
148
New
41
Increased
22
Reduced
20
Closed
37

Top Buys

Rank Stock Value
1
NVVE
Nuvve Holding Corp
NVVE
+$4.72M
2
TLND
Talend S.A. American Depositary Shares
TLND
+$3.42M
3
DZSI
DZS Inc. Common Stock
DZSI
+$2.83M
4
THER
THERATECHNOLOGIES INC COM
THER
+$2.73M
5
PBYI icon
Puma Biotechnology
PBYI
+$2.53M

Top Sells

Rank Stock Value
1
BLBD icon
Blue Bird Corp
BLBD
+$3.79M
2
CLDR
Cloudera, Inc.
CLDR
+$3.52M
3
FFIV icon
F5
FFIV
+$3.34M
4
BFX
BowFlex Inc.
BFX
+$3M
5
COHR
Coherent Inc
COHR
+$3M

Sector Composition

Rank Sector Weight
1 Technology 20.62%
2 Healthcare 12.27%
3 Consumer Discretionary 3.1%
4 Financials 2.19%
5 Industrials 1.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUWE icon
51
Nuwellis
NUWE
$148K
– –
0
– –
NVVEW
52
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
$694K 0.34%
+385,168
New +$1.01M
NVNO
53
enVVeno Medical
NVNO
$7.14M
$671K 0.33%
+2,878
New +$801K
DCOY
54
Decoy Therapeutics
DCOY
$2.31M
$629K 0.3%
12
+2
+20% +$115K
ATEN icon
55
A10 Networks
ATEN
$2.16B
$628K 0.3%
65,382
-105,994
-62% -$1.04M
ARDS
56
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$622K 0.3%
105,413
+17,481
+20% +$118K
EVOK
57
DELISTED
Evoke Pharma
EVOK
$616K 0.3%
+2,337
New +$935K
EXFO
58
DELISTED
EXFO INC.
EXFO
$527K 0.26%
+123,732
New +$495K
BMRN icon
59
BioMarin Pharmaceuticals
BMRN
$11.6B
$515K 0.25%
+6,820
New +$557K
WFC icon
60
Wells Fargo
WFC
$266B
$505K 0.24%
+12,938
New +$458K
DAIO icon
61
Data I/O
DAIO
$30.4M
$488K 0.24%
89,963
+39,576
+79% +$211K
HSDT icon
62
Solana Company
HSDT
$98.1M
$428K 0.21%
+1
New +$553K
APPS icon
63
Digital Turbine
APPS
$1.09B
$422K 0.2%
5,247
-8,182
-61% -$598K
PGR icon
64
Progressive
PGR
$122B
$339K 0.16%
+3,546
New +$322K
CYTHW
65
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$333K 0.16%
88,690
– –
CTO
66
CTO Realty Growth
CTO
$827M
$315K 0.15%
18,165
-9,675
-35% -$157K
HTGM
67
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$299K 0.14%
+4,562
New +$346K
CIO
68
DELISTED
City Office REIT
CIO
$264K 0.13%
24,900
– –
COLD icon
69
Americold
COLD
$4.03B
$260K 0.13%
+6,750
New +$243K
PSTL
70
Postal Realty Trust
PSTL
$698M
$260K 0.13%
15,113
+1,508
+11% +$24.6K
EQC
71
DELISTED
Equity Commonwealth
EQC
$246K 0.12%
8,853
+1,000
+13% +$28.3K
NLY icon
72
Annaly Capital Management
NLY
$17.2B
$234K 0.11%
6,800
– –
GANX icon
73
Gain Therapeutics
GANX
$74.6M
$232K 0.11%
+15,532
New +$204K
QTS
74
DELISTED
QTS REALTY TRUST, INC.
QTS
$219K 0.11%
+3,525
New +$220K
AVYA
75
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$208K 0.1%
+70,500
New +$1.89M
1 2
3
4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Worth Venture Partners held 148 positions worth $206M, up 63% from $126M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Worth Venture Partners's Q1 2021 filing shows 41 new, 22 increased, 20 reduced and 37 closed positions. Its largest new stake was Nuvve Holding Corp: 1 share worth $1.93M. The largest sale was Blue Bird Corp, an estimated $3.79M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Worth Venture Partners's largest Q1 2021 buy was Nuvve Holding Corp: 1 share worth $1.93M.
  • Worth Venture Partners added most to THERATECHNOLOGIES INC COM in Q1 2021, an estimated $2.73M increase.
  • Worth Venture Partners's biggest Q1 2021 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $2.03M.
  • Worth Venture Partners fully exited Blue Bird Corp in Q1 2021, selling an estimated $3.79M.
  • Worth Venture Partners's ten largest holdings make up 40% of its $206M portfolio in Q1 2021.
  • Worth Venture Partners opened 41 new positions and closed 37 in Q1 2021.
  • Worth Venture Partners's portfolio value rose 63% quarter-over-quarter to $206M.

Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.